PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Cancer Research and Treatment10.4143/crt.2014.364201648198-105Is Human Kallikrein 11 in Non-small Cell Lung Cancer Treated Chemoradiotherapy Associated with Survival?Dilek Unal, Celalettin Eroglu, Arzu Tasdemir, Hatice Karaman, Neslihan Kurtul, Arzu Oguz, Sema Sezgin Goksu, Bunyamin Kaplanhttp://e-crt.org/upload/pdf/crt-2014-364.pdf, http://e-crt.org/journal/view.php?doi=10.4143/crt.2014.364, http://www.e-crt.org/upload/pdf/crt-2014-364.pdf
Lung Cancer10.1016/0169-5002(94)94461-x199411178Longterm survival results for patients with locally advanced non-small cell lung carcinoma (NSCLC) treated with aggressive concurrent chemoradiotherapy. (CT/TRT)https://api.elsevier.com/content/article/PII:016950029494461X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:016950029494461X?httpAccept=text/plain
Lung Cancer10.1016/s0169-5002(11)70224-0201171S4387P ORAL GLUTAMINE SUPPLEMENTATION HAS NO NEGATIVE IMPACT ON SURVIVAL IN LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER TREATED WITH CONCURRENT CHEMORADIOTHERAPYE. Topkan, O. Yuksel, A. Kotek, C. Parlak, B. Pehlivanhttps://api.elsevier.com/content/article/PII:S0169500211702240?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0169500211702240?httpAccept=text/plain
Lung Cancer10.1016/0169-5002(94)94505-5199411189Mitomycin-vindesine-platin (MVP) plus chemoradiotherapy (CR) for primary inoperable non small cell lung cancer (NSCLC)https://api.elsevier.com/content/article/PII:0169500294945055?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:0169500294945055?httpAccept=text/plain
BMC Cancer10.1186/1471-2407-12-5022012121Influence of oral glutamine supplementation on survival outcomes of patients treated with concurrent chemoradiotherapy for locally advanced non-small cell lung cancerErkan Topkan, Cem Parlak, Savas Topuk, Berrin Pehlivanhttp://link.springer.com/content/pdf/10.1186/1471-2407-12-502.pdf, http://link.springer.com/article/10.1186/1471-2407-12-502/fulltext.html, http://link.springer.com/content/pdf/10.1186/1471-2407-12-502
BMC Cancer10.1186/1471-2407-11-4472011111TNFRSF1B +676 T>G polymorphism predicts survival of non-Small cell lung cancer patients treated with chemoradiotherapyXiaoxiang Guan, Zhongxin Liao, Hongxia Ma, Ji Qian, Zhensheng Liu, Xianglin Yuan, Daniel Gomez, Ritsuko Komaki, Li-E Wang, Qingyi Weihttp://link.springer.com/content/pdf/10.1186/1471-2407-11-447.pdf, http://link.springer.com/article/10.1186/1471-2407-11-447/fulltext.html, http://link.springer.com/content/pdf/10.1186/1471-2407-11-447, https://link.springer.com/content/pdf/10.1186/1471-2407-11-447.pdf
Lung Cancer10.1016/j.lungcan.2017.04.0062017108222-227Association between intensity modulated radiotherapy and survival in patients with stage III non-small cell lung cancer treated with chemoradiotherapyMatthew Koshy, Renuka Malik, Michael Spiotto, Usama Mahmood, Chad G. Rusthoven, David J. Sherhttps://api.elsevier.com/content/article/PII:S0169500217302933?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0169500217302933?httpAccept=text/plain
BMC Cancer10.1186/1471-2407-12-272012121Risk factors associated with fatal pulmonary hemorrhage in locally advanced non-small cell lung cancer treated with chemoradiotherapyMasami Ito, Seiji Niho, Keiji Nihei, Kiyotaka Yoh, Hironobu Ohmatsu, Yuichiro Ohehttp://link.springer.com/content/pdf/10.1186/1471-2407-12-27.pdf, http://link.springer.com/article/10.1186/1471-2407-12-27/fulltext.html, http://link.springer.com/content/pdf/10.1186/1471-2407-12-27, https://link.springer.com/content/pdf/10.1186/1471-2407-12-27.pdf
Clinical Lung Cancer10.1016/s1525-7304(11)70735-5200124290Commentary on “Preliminary Report on Reduction of Esophagitis by Amifostinein Patients with Non–Small-Cell Lung Cancer Treated with Chemoradiotherapy”Rob MacRae, Hak Choyhttps://api.elsevier.com/content/article/PII:S1525730411707355?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1525730411707355?httpAccept=text/plain
Clinical Nutrition10.1016/j.clnu.2016.06.01220173641022-1028The effects of oral glutamine on clinical and survival outcomes of non-small cell lung cancer patients treated with chemoradiotherapyKanyilmaz Gul, Koc Mehmet, Aktan Meryemhttps://api.elsevier.com/content/article/PII:S0261561416301455?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0261561416301455?httpAccept=text/plain